Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/101155
DC FieldValueLanguage
dc.contributor.authorOliveira, Joelizy-
dc.contributor.authorSilva, Thaís Costa e-
dc.contributor.authorCabral, Ana C.-
dc.contributor.authorLavrador, Marta-
dc.contributor.authorAlmeida, Filipe F.-
dc.contributor.authorMacedo, António-
dc.contributor.authorSaraiva, Carlos-
dc.contributor.authorFernandez-Llimos, Fernando-
dc.contributor.authorCaramona, M. Margarida-
dc.contributor.authorFigueiredo, Isabel V.-
dc.contributor.authorCastel-Branco, M. Margarida-
dc.date.accessioned2022-08-10T15:31:48Z-
dc.date.available2022-08-10T15:31:48Z-
dc.date.issued2022-07-10-
dc.identifier.issn1885-642Xpt
dc.identifier.issn1886-3655pt
dc.identifier.urihttps://hdl.handle.net/10316/101155-
dc.description.abstractBackground: Therapy management in patients suffering from mental health disorders is complex and the risks derived from changes or interruptions of treatment should not be ignored. Medication reconciliation in psychiatry may reduce medication errors and promote patient safety during transitions of care. Objective: To identify the influence of complementary information sources in the construction of the best possible medication history, and to ascertain the potential clinical impact of discrepancies identified in a medication reconciliation service. Methods: An observational study was conducted in an acute mental hospital unit, with a further validation in an internal medicine unit. Adult patients taking at least one medicine admitted in the unit were included. Patients/caregivers were interviewed upon admission and the information gathered was compared with hospital medical and shared electronic medical records. Once the best possible medication history was gathered, therapeutic information was reconciled against the prescription on admission to identify discrepancies. Potential clinical impact of medication errors was classified using the International Safety Classification. Results: During the study period, 148 patients were admitted, 50.7% females, mean age 54.6 years (SD=16.3). Collaboration of a caregiver was a needed in 74% of the interviews. In total, 1,147 drugs were considered to obtain patients’ best possible medication history. After reconciliation, 560 clinically sound intentional discrepancies were identified and 359 discrepancies required further clarification from prescribers: 84.12% “drug omission”, 5.57% “drug substitution”, 6.96% “dose change”, and 3.34% “dosage frequency change”. Potential clinical impact of these medication discrepancies was classified as: 95 mild, 100 moderate, and 29 severe medication errors. Conclusion: About 1 in three intentional discrepancies observed in a pharmacists-led medication reconciliation service required further clarification from prescribers, being 80% of them unintentional discrepancies. Results highlight the importance of the caregiver as source of information for the psychiatric patient, the relevance of analyzing shared electronic health records until 6 months before, and the need to use hospital medical records efficiently. Additionally, 29 discrepancies were classified as errors with potentially severe clinical impact. A medication reconciliation service is concluded to be feasible and necessary in a mental health unit.pt
dc.language.isoengpt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt
dc.subjectMedication Errorspt
dc.subjectMedication Reconciliation; Patient Safety; Transitional Carept
dc.subjectMedication Errors; Medication Reconciliation; Patient Safety; Transitional Carept
dc.subjectMedication Errors; Medication Reconciliation; Patient Safety; Transitional Carept
dc.titlePharmacist-led medication reconciliation on admission to an acute psychiatric hospital unitpt
dc.typearticleen_US
degois.publication.firstPage01pt
degois.publication.lastPage08pt
degois.publication.issue2pt
degois.publication.titlePharmacy Practicept
dc.date.updated2022-07-31T09:46:40Z-
dc.peerreviewedyespt
dc.identifier.doi10.18549/pharmpract.2022.2.2650pt
degois.publication.volume20pt
dc.description.version3910-3178-31BA | MARIA MARGARIDA COUTINHO DE SEABRA CASTEL-BRANCO CAETANO-
dc.description.versionN/A-
dc.identifier.slugcv-prod-3024228-
dc.date.embargo2022-07-10*
uc.date.periodoEmbargo0pt
item.languageiso639-1en-
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypearticle-
item.cerifentitytypePublications-
crisitem.author.deptFaculty of Pharmacy-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.researchunitICBR Coimbra Institute for Clinical and Biomedical Research-
crisitem.author.researchunitICBR Coimbra Institute for Clinical and Biomedical Research-
crisitem.author.parentresearchunitFaculty of Medicine-
crisitem.author.parentresearchunitFaculty of Medicine-
crisitem.author.orcid0000-0002-8582-7853-
crisitem.author.orcid0000-0003-2180-2718-
crisitem.author.orcid0000-0002-8529-9595-
crisitem.author.orcid0000-0003-1950-9360-
crisitem.author.orcid0000-0002-6533-9932-
Appears in Collections:FFUC- Artigos em Revistas Internacionais
Show simple item record

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons